Comparison of the frequency of nucleotide variation in the mtDNA D-loop region between stomach and other tumor cell lines. Comparison of the frequency.

Slides:



Advertisements
Similar presentations
The Build-up of the Red Sequence at z
Advertisements

DNA damage foci in irradiated cells.
Regional lymph nodes and distal extracranial metastases are not a reliable surrogate for actionable mutation in brain metastases. Regional lymph nodes.
Phosphorylation and sequence disorder in microtubule-associated protein Tau.A, schematic illustration of the domain profile of Tau with all known phosphorylation.
Structures of SET Domain Proteins
Somatic mutations in mitochondrial DNA do not associate with nuclear microsatellite instability in gastrointestinal cancer  Simó Schwartz, M.D., Ph.D.*,†,
High-throughput analysis of informative CpG sites for the four studied tumor suppressor genes (A-D). High-throughput analysis of informative CpG sites.
Frequencies of immune cell types show much stronger variations between tumor types in the tumor infiltrate compared with the spleen and tumor-draining.
Apoptosis and necroptosis result in mitochondria dysfunction and injury. Apoptosis and necroptosis result in mitochondria dysfunction and injury. L929.
Genomewide profiling of chromatin accessibility in prostate cancer specimens Genomewide profiling of chromatin accessibility in prostate cancer specimens.
Quantification of MHC-I, β2m, and T-cell subsets.
Cancer mutations in enriched RBP motifs.
Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.
Tumor phenotyping. Tumor phenotyping. (A) Comparative growth behavior of tumors after grafting R versus VR J2A, H1, and I1 cell lines in independent experiments.
Sequence variation of 16S rRNA gene primer-binding sites.
Adipocytes sequester daunorubicin (DNR).
Frequency and kinetics of killer cell apoptosis are dependent on functional conjugations with multiple NALM-6 tumor cells. Frequency and kinetics of killer.
Fig. 1. Detection of circulating tumor DNA in CRPC patients.
Nucleotide sequences of the IS1016-bexAdeletion region of type b strain Hib and type a strains 1, 2, and 5. Nucleotide sequences of the IS1016-bexAdeletion.
TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.
Mice immunized twice with RRBC showed superior protection to tumor challenge with αGal-positive MC38 colon carcinoma cells compared with mock-immunized.
BRCA1 promoter methylation detected in the peripheral blood and corresponding tumor. BRCA1 promoter methylation detected in the peripheral blood and corresponding.
Performance and potency comparisons of qHTS runs.
Interaction of aggregates with CAF network structures.
CDCP1 colocalizes and interacts with MT1-MMP.
Expression profile of RSPO1 and 2 in gastric cancer.
Interaction of MAPJD with E-box sequence of the RIOK1 gene.
A, high-resolution methylation analysis of ZNF545 promoter by BGS in representative carcinoma cell lines. A, high-resolution methylation analysis of ZNF545.
A549 cells internalize NHF-ATP and NHF-ATP colocalizes with HMWFD
Protein expression profile in a dasatinib-resistant cell line.
DNA recombination at sites of replication damage in BLM-deficient cells. DNA recombination at sites of replication damage in BLM-deficient cells. A. Nucleotide.
Correlation of miR-21 expression levels with DEGs in 28 bladder cancer cell lines. Correlation of miR-21 expression levels with DEGs in 28 bladder cancer.
Correlation between serum visfatin concentrations and the clinical stage (A) and tumor size (B, C) of HCCs. A and B, the correlations were determined by.
Predictive value of the FGFR3 mutation assay increases with multiple consecutive FGFR3-positive urine samples. Predictive value of the FGFR3 mutation assay.
DNA damage-induced RPA foci in asynchronous cells labeled with BUdR.
A, unsupervised clustering of all BRCA1 (red), BRCA2 (blue), and sporadic (green) breast tumors of our collection using the regions reported as discriminative.
Positions of the EGFR exon 20 insertions identified over a 3-year period and comparison with the spectrum of EGFR exon 19 and HER2 insertion mutations.
Expression of XCR1 in normal ovarian surface epithelium and the IOSE and borderline EOC cell lines. Expression of XCR1 in normal ovarian surface epithelium.
Tumor and serum levels of murine IL-12.
CLIC1 is upregulated in invadopodia of fibrin-embedded tumor and endothelial cells. CLIC1 is upregulated in invadopodia of fibrin-embedded tumor and endothelial.
HPV–human protein network map.
Two-way, unsupervised hierarchical clustering representing the 60 tumor cell lines (vertical axis) and the analyzed total, phospho- and cleaved proteins.
Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.
Ki-67 expression in M31- and H3-treated tumors (A) and respective Ki-67 labeling indices in the two groups of tumors (B). Ki-67 expression in M31- and.
Number of identical D-loop DNA clones detected in 10 DNA clones derived from liver tumor tissues. Number of identical D-loop DNA clones detected in 10.
Characterization of DNA-PK and PARP-1 levels and activities in the cell lines studied. Characterization of DNA-PK and PARP-1 levels and activities in the.
Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.
Delineating cancer evolution with single-cell sequencing
Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.
Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.
VEGF165 stimulates migration of HMVECs
The CCR5+ population of SUM-159 cells is enriched with tumor-initiating cells. The CCR5+ population of SUM-159 cells is enriched with tumor-initiating.
The activation of PKC-δ and JNK1 is essential for doxorubicin-induced senescence. The activation of PKC-δ and JNK1 is essential for doxorubicin-induced.
Concordance between the genomic landscape identified by whole-exome sequencing of plasma cfDNA and tumor; DNA and recurrence of KDR/VEGFR2 oncogenic mutations.
Establishment of HeLa/rtTAA/TRE-N1-IC cell line.
Enrichment of two rare SNPs among ABC DLBCL tumors.
Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.
Identification of putative TET1 targets in TNBC
A, heatmap of copy number alterations determined by array CGH for a panel of 79 frozen NSCLC samples. A, heatmap of copy number alterations determined.
Correlations between APOBEC expression and immune cell markers across 22 cancer types. Correlations between APOBEC expression and immune cell markers across.
MPD-L1–transfected 300 cells do not bind to mB7-1–transfected 300 cells. mPD-L1–transfected 300 cells do not bind to mB7-1–transfected 300 cells. Cell-to-cell.
Venn diagram showing the overlap of PD-L1 overexpression, MSI-NGS–high, and TML-high in all gastrointestinal tumors, with all three markers tested (N =
AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. A,
A, study design for measuring the feasibility, concordance, and accuracy of a plasma-based cfDNA sequencing test compared with biopsy-based sequencing.
Reduced interorigin distance in BLM-deficient cells.
Identification and characterization of activated integrin pathway module by signal transduction representation (A) and unsupervised hierarchical clustering.
miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro.
Loss of NQO1 expression inhibits invasion of NSCLC
WEE1 inhibition followed by TRAIL treatment results in apoptotic cell death in MB231 cells. WEE1 inhibition followed by TRAIL treatment results in apoptotic.
Fig. 3 Genome editing of the MSTN gene.
Presentation transcript:

Comparison of the frequency of nucleotide variation in the mtDNA D-loop region between stomach and other tumor cell lines. Comparison of the frequency of nucleotide variation in the mtDNA D-loop region between stomach and other tumor cell lines. D-loop DNA sequences derived from 21 stomach tumor and 55 other tumor cell lines were analyzed to detect sequence variation at each site. X axis, nucleotide position of mtDNA as described in Fig. 1 legend. Solid rods, frequency of nucleotide variation found in stomach (red) and other tumor (green) cell lines. Several nucleotide positions of >30% frequency in stomach cell line are presented its nucleotide number at each position of the D-loop regions from np 16,000 to 16,569 (A) and from np 1 to 600 (B). Haruko Yoneyama et al. Mol Cancer Res 2005;3:14-20 ©2005 by American Association for Cancer Research